Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification
International Journal of Molecular Sciences · 31.01.2023 · 24 (3) · 2686
DOI: 10.3390/ijms24032686 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.01.2023. Verfasst von Kristin Fritsche und 3 weiteren Autor:innen. Beteiligte Einrichtung: German Federal Institute for Risk Assessment, Department Food Safety, Max-Dohrn-Str. 8-10, 10589 Berlin, Germany. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Metabolic Syndrome, Metabolic Diseases, Endocrine Disruptors. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, the European Union’s Horizon 2020 research and innovation program, Horizon Europe, the European Union’s 2021–2027 framework program for the funding of research and innovation.
Abstract (Originalsprache)
The liver is the central metabolic organ of the body. The plethora of anabolic and catabolic pathways in the liver is tightly regulated by physiological signaling but may become imbalanced as a consequence of malnutrition or exposure to certain chemicals, so-called metabolic endocrine disrupters, or metabolism-disrupting chemicals (MDCs). Among different metabolism-related diseases, obesity and non-alcoholic fatty liver disease (NAFLD) constitute a growing health problem, which has been associated with a western lifestyle combining excessive caloric intake and reduced physical activity. In the past years, awareness of chemical exposure as an underlying cause of metabolic endocrine effects has continuously increased. Within this review, we have collected and summarized evidence that certain environmental MDCs are capable of contributing to metabolic diseases such as liver steatosis and cholestasis by different molecular mechanisms, thereby contributing to the metabolic syndrome. Despite the high relevance of metabolism-related diseases, standardized mechanistic assays for the identification and characterization of MDCs are missing. Therefore, the current state of candidate test systems to identify MDCs is presented, and their possible implementation into a testing strategy for MDCs is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- German Federal Institute for Risk Assessment, Department Food Safety, Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.
- German Federal Institute for Risk Assessment, Department Pesticides Safety, Max-Dohrn-Str. 8-10, 10589 Berlin, Germany.
ORCID-Profile: Kristin Fritsche, Philip Marx-Stoelting
Förderung
- European Union
- the European Union’s Horizon 2020 research and innovation program
- Horizon Europe, the European Union’s 2021–2027 framework program for the funding of research and innovation
Zitieren
APA
Fritsche, K., Ziková-Kloas, A., Marx-Stoelting, P., & Braeuning, A. (2023). Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification. International Journal of Molecular Sciences, 24(3), 2686. https://doi.org/10.3390/ijms24032686
Vancouver
Fritsche K, Ziková-Kloas A, Marx-Stoelting P, Braeuning A. Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification. International Journal of Molecular Sciences. 2023;24(3):2686. doi:10.3390/ijms24032686
BibTeX
@article{Fritsche2023,
author = {Fritsche, Kristin and Ziková-Kloas, Andrea and Marx-Stoelting, Philip and Braeuning, Albert},
title = {Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2686},
doi = {10.3390/ijms24032686}
}
EUVIMED